FGA cells in culture demonstrate variable stimulatory responses to acute GnRH administration, while treatment with GnRH agonist decreased tumor secretion (as a result of the desensitizing effect of medication) in only one out of three tumors [107]. Here, GNRH1 is linked to neoplasm.